Company · CIK 0000059478 · SIC 2834 — Pharmaceutical Preparations · NYSE
ELI LILLY & Co · LLY
Insider activity reported against this company. All insider holders · Files at: SCTX, ELAN, ZYME, CYPH, CLCD, SYRE, ZSAN. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 AForm 4 → | Sep 22, 4:15 pm EDT | Gabrielle SulzbergerDirector | 4 | $1,164.89 | $4,958 | 3,012 | — | |
| Sep 21, 2026 AForm 4 → | Sep 22, 4:14 pm EDT | Juan R LucianoDirector | 14 | $1,164.89 | $15,917 | 16,957 | — | |
| Sep 21, 2026 AForm 4 → | Sep 22, 4:12 pm EDT | J Erik FyrwaldDirector | 9 | $1,164.89 | $9,917 | 75,536 | — | |
| Sep 21, 2026 AForm 4 → | Sep 22, 4:11 pm EDT | Ralph AlvarezDirector | 11 | $1,164.89 | $12,417 | 55,838 | — | |
| Sep 2, 2026 GForm 4 → | Sep 4, 4:18 pm EDT | Edgardo HernandezEVP & Pres., Mfg. Operations | 13 | — | — | 46,083 | — | |
| Sep 2, 2026 GForm 4 → | Sep 4, 4:17 pm EDT | Eric DozierEVP, Chief People Officer | 216 | — | — | 14,239 | — | |
| Aug 17, 2026 AForm 4 → | Aug 18, 4:24 pm EDT | Gabrielle SulzbergerDirector | 4 | $1,183.16 | $4,958 | 3,004 | — | |
| Aug 17, 2026 AForm 4 → | Aug 18, 4:23 pm EDT | Juan R LucianoDirector | 13 | $1,183.16 | $15,917 | 16,918 | — | |
| Aug 17, 2026 AForm 4 → | Aug 18, 4:22 pm EDT | J Erik FyrwaldDirector | 8 | $1,183.16 | $9,917 | 75,418 | — | |
| Aug 17, 2026 AForm 4 → | Aug 18, 4:21 pm EDT | Ralph AlvarezDirector | 10 | $1,183.16 | $12,417 | 55,745 | — | |
| Aug 17, 2026 SForm 4 → | Aug 18, 4:20 pm EDT | Patrik JonssonEVP & President, LLY Int'l | 6,500 | $1,175.10 | $7,638,150 | 54,147 | −10.7% | 10b5-1 |
| Aug 10, 2026 SForm 4 → | Aug 11, 4:31 pm EDT | Donald A ZakrowskiSVP, Finance, & CAO | 2,000 | $1,185.01 | $2,370,020 | 1,526 | −56.7% | 10b5-1 |
| Aug 7, 2026 SForm 4 → | Aug 10, 4:19 pm EDT | Anat HakimEVP, GC & Secretary | 5,000 | $1,190.00 | $5,950,000 | 11,875 | −29.6% | 10b5-1 |
| Aug 1, 2026 FMForm 4 → | Aug 3, 4:42 pm EDT | Melissa SeymourEVP, Global Quality | 1,420 | $1,148.84 | $504,004 | 1,067 | — | |
| Jul 20, 2026 AForm 4 → | Jul 21, 4:40 pm EDT | Gabrielle SulzbergerDirector | 4 | $1,146.90 | $4,958 | 3,000 | — | |
| Jul 20, 2026 AForm 4 → | Jul 21, 4:39 pm EDT | Juan R LucianoDirector | 14 | $1,146.90 | $15,917 | 16,905 | — | |
| Jul 20, 2026 AForm 4 → | Jul 21, 4:39 pm EDT | J Erik FyrwaldDirector | 9 | $1,146.90 | $9,917 | 75,410 | — | |
| Jul 20, 2026 AForm 4 → | Jul 21, 4:37 pm EDT | Ralph AlvarezDirector | 11 | $1,146.90 | $12,417 | 55,734 | — | |
| Jun 15, 2026 AForm 4 → | Jun 16, 4:25 pm EDT | Gabrielle SulzbergerDirector | 4 | $1,129.35 | $4,958 | 2,995 | — | |
| Jun 15, 2026 AForm 4 → | Jun 16, 4:24 pm EDT | Juan R LucianoDirector | 14 | $1,129.35 | $15,917 | 16,891 | — | |
| Jun 15, 2026 AForm 4 → | Jun 16, 4:14 pm EDT | J Erik FyrwaldDirector | 9 | $1,129.35 | $9,917 | 75,401 | — | |
| Jun 15, 2026 AForm 4 → | Jun 16, 4:13 pm EDT | Ralph AlvarezDirector | 11 | $1,129.35 | $12,417 | 55,723 | — | |
| Jun 10, 2026 SForm 4 → | Jun 11, 4:23 pm EDT | Ilya YuffaEVP&Pres, LLY USA&Global Capab | 2,500 | $1,150.77 | $2,876,925 | 29,804 | −7.74% | 10b5-1 |
| Sep 22, 2025 GForm 4 → | Sep 11, 2026, 4:16 pm EDT | Melissa SeymourEVP, Global Quality | 29 | — | — | 1,038 | — | late |
| Mar 12, 2019 SForm 4 → | Mar 13, 12:47 pm EDT | Stephen F FrySVP, HR & Diversity | 14,847 | $123.16 | $1,828,557 | 109,663 | −11.9% | plan? |
| Mar 1, 2019 SForm 4 → | Mar 5, 3:51 pm EST | Donald A ZakrowskiChief Accounting Officer | 1,000 | $127.01 | $127,010 | 5,595 | −15.2% | plan? |
| Mar 1, 2019 SForm 4 → | Mar 4, 2:13 pm EST | LILLY ENDOWMENT INC10% Owner | 210,000 | $128.43 | $26,971,215 | 117,015,304 | −0.18% | plan? |
| Feb 28, 2019 SForm 4 → | Mar 1, 1:25 pm EST | LILLY ENDOWMENT INC10% Owner | 200,000 | $126.73 | $25,345,017 | 117,225,304 | −0.17% | plan? |
| Feb 22, 2019 SForm 4 → | Feb 25, 4:06 pm EST | LILLY ENDOWMENT INC10% Owner | 195,000 | $124.19 | $24,217,635 | 117,425,304 | −0.17% | plan? |
| Feb 19, 2019 AForm 4 → | Feb 20, 3:56 pm EST | Ralph AlvarezDirector | 89 | $122.13 | $10,870 | 43,462 | — | plan? |
| Feb 19, 2019 AForm 4 → | Feb 20, 3:56 pm EST | Juan R LucianoDirector | 87 | $122.13 | $10,625 | 8,294 | — | plan? |
| Feb 19, 2019 AForm 4 → | Feb 20, 3:55 pm EST | Ellen R MarramDirector | 55 | $122.13 | $6,717 | 56,255 | — | plan? |
| Feb 19, 2019 AForm 4 → | Feb 20, 3:53 pm EST | Jackson P TaiDirector | 16 | $122.13 | $1,954 | 54,263 | — | plan? |
| Feb 19, 2019 AForm 4 → | Feb 20, 3:53 pm EST | Karen WalkerDirector | 81 | $122.13 | $9,893 | 292 | — | plan? |
| Feb 19, 2019 SForm 4 → | Feb 20, 1:35 pm EST | LILLY ENDOWMENT INC10% Owner | 205,000 | $122.48 | $25,108,513 | 117,620,304 | −0.17% | plan? |
| Feb 16, 2019 FMForm 4 → | Feb 20, 3:52 pm EST | Johna NortonSenior VP, Global Quality | 65 | $122.48 | $2,082 | 65 | — | plan? |
| Feb 15, 2019 SForm 4 → | Feb 20, 3:37 pm EST | Enrique A ConternoSVP&Pres, LillyDiab & LillyUSA | 25,000 | $121.00 | $3,025,000 | 132,962 | −15.8% | plan? |
| Feb 4, 2019 AForm 4/A → | Feb 20, 3:50 pm EST | Donald A ZakrowskiChief Accounting Officer | 3,245 | $120.17 | $389,952 | 6,595 | — | plan? |
| Feb 4, 2019 AForm 4/A → | Feb 20, 3:47 pm EST | Aarti S. ShahSVP & CIO | 5,940 | $120.17 | $713,810 | 20,225 | — | plan? |
| Feb 4, 2019 AForm 4/A → | Feb 20, 3:46 pm EST | Johna NortonSenior VP, Global Quality | 2,960 | $120.17 | $355,703 | 20,819 | — | plan? |
| Feb 4, 2019 AForm 4/A → | Feb 20, 3:45 pm EST | Stephen F FrySVP, HR & Diversity | 19,405 | $120.17 | $2,331,899 | 124,510 | — | plan? |
| Feb 4, 2019 AForm 4/A → | Feb 20, 3:43 pm EST | Enrique A ConternoSVP&Pres, LillyDiab & LillyUSA | 26,682 | $120.17 | $3,206,376 | 157,962 | — | plan? |
| Feb 4, 2019 AForm 4/A → | Feb 20, 3:42 pm EST | Michael J HarringtonSenior VP and General Counsel | 28,156 | $120.17 | $3,383,507 | 126,300 | — | plan? |
| Feb 4, 2019 AForm 4/A → | Feb 20, 3:40 pm EST | Joshua L SmileySVP and CFO | 9,955 | $120.17 | $1,196,292 | 29,984 | — | plan? |
| Feb 4, 2019 AForm 4/A → | Feb 20, 3:39 pm EST | Myles O'NeillSVP & Pres., Mfg. Operations | 13,283 | $120.17 | $1,596,218 | 40,646 | — | plan? |
| Feb 4, 2019 AForm 4 → | Feb 6, 8:29 pm EST | Donald A ZakrowskiChief Accounting Officer | 3,243 | $120.17 | $389,711 | 6,593 | — | plan? amended |
| Feb 4, 2019 AForm 4 → | Feb 6, 8:02 pm EST | Joshua L SmileySVP and CFO | 9,954 | $120.17 | $1,196,172 | 29,983 | — | plan? amended |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:58 pm EST | Alfonso G ZuluetaSVP & President, Lilly Int'l | 21,224 | $120.17 | $2,550,488 | 67,806 | — | plan? |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:53 pm EST | Anne E. WhiteSVP & Pres-Lilly Oncology | 7,246 | $120.17 | $870,752 | 21,043 | — | plan? |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:39 pm EST | Daniel SkovronskySVP, CSO, and Pres. LRL | 15,619 | $120.17 | $1,876,935 | 70,818 | — | plan? |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:36 pm EST | Aarti S. ShahSVP & CIO | 5,939 | $120.17 | $713,690 | 20,224 | — | plan? amended |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:29 pm EST | David A RicksPresident & CEO, Director | 26,567 | $120.17 | $3,192,556 | 152,790 | — | plan? |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:22 pm EST | Johna NortonSenior VP, Global Quality | 2,958 | $120.17 | $355,463 | 20,817 | — | plan? amended |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:16 pm EST | Michael J HarringtonSenior VP and General Counsel | 28,155 | $120.17 | $3,383,386 | 126,299 | — | plan? amended |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:10 pm EST | Stephen F FrySVP, HR & Diversity | 19,404 | $120.17 | $2,331,779 | 124,509 | — | plan? amended |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:02 pm EST | Enrique A ConternoSVP&Pres, LillyDiab & LillyUSA | 26,681 | $120.17 | $3,206,256 | 157,961 | — | plan? amended |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:00 pm EST | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 7,411 | $120.17 | $890,580 | 26,820 | — | plan? |
| Feb 1, 2019 AFMForm 4 → | Feb 6, 8:10 pm EST | Myles O'NeillSVP & Pres., Mfg. Operations | 17,939 | $120.14 | $1,768,200 | 40,645 | — | plan? late amended |
| Feb 1, 2019 FMForm 4 → | Feb 5, 7:09 pm EST | Alfonso G ZuluetaSVP & President, Lilly Int'l | 14,086 | $119.86 | $523,069 | 46,582 | — | plan? |
| Feb 1, 2019 FMForm 4 → | Feb 5, 7:04 pm EST | David A RicksPresident & CEO, Director | 17,707 | $119.86 | $657,432 | 126,223 | — | plan? |
| Feb 1, 2019 FMForm 4 → | Feb 5, 6:59 pm EST | Michael J HarringtonSenior VP and General Counsel | 17,182 | $119.86 | $527,863 | 98,144 | — | plan? |
| Feb 1, 2019 FMForm 4 → | Feb 5, 6:55 pm EST | Stephen F FrySVP, HR & Diversity | 12,884 | $119.86 | $478,841 | 105,105 | — | plan? |
| Feb 1, 2019 FMForm 4 → | Feb 5, 6:49 pm EST | Enrique A ConternoSVP&Pres, LillyDiab & LillyUSA | 17,698 | $119.86 | $656,353 | 131,280 | — | plan? |
| Feb 1, 2019 FMForm 4 → | Feb 5, 6:43 pm EST | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 4,825 | $119.86 | $178,831 | 19,409 | — | plan? |
| Jan 31, 2019 SForm 4 → | Feb 4, 4:32 pm EST | Alfonso G ZuluetaSVP & President, Lilly Int'l | 4,000 | $120.00 | $480,000 | 41,224 | −8.84% | plan? |
| Jan 22, 2019 AForm 4 → | Jan 24, 8:40 pm EST | Karen WalkerDirector | 85 | $117.09 | $9,953 | 211 | — | plan? |
| Jan 22, 2019 AForm 4 → | Jan 24, 6:26 pm EST | Jackson P TaiDirector | 17 | $117.09 | $1,991 | 54,847 | — | plan? |
| Jan 22, 2019 AForm 4 → | Jan 24, 6:19 pm EST | Ellen R MarramDirector | 58 | $117.09 | $6,791 | 56,200 | — | plan? |
| Jan 22, 2019 AForm 4 → | Jan 24, 6:14 pm EST | Juan R LucianoDirector | 91 | $117.09 | $10,655 | 8,207 | — | plan? |
| Jan 22, 2019 AForm 4 → | Jan 24, 6:07 pm EST | Ralph AlvarezDirector | 93 | $117.09 | $10,889 | 43,373 | — | plan? |
| Jan 17, 2019 SForm 4 → | Jan 18, 1:14 pm EST | LILLY ENDOWMENT INC10% Owner | 136,577 | $118.33 | $16,161,281 | 117,825,304 | −0.12% | plan? |
| Jan 16, 2019 SForm 4 → | Jan 17, 1:15 pm EST | LILLY ENDOWMENT INC10% Owner | 1,657 | $117.87 | $195,315 | 117,961,881 | −0.00% | plan? |
| Jan 15, 2019 SForm 4 → | Jan 16, 2:36 pm EST | LILLY ENDOWMENT INC10% Owner | 51,766 | $117.74 | $6,095,136 | 117,963,538 | −0.04% | plan? |
| Dec 17, 2018 AForm 4 → | Dec 19, 4:09 pm EST | Karen WalkerDirector | 126 | $115.81 | $14,592 | 126 | — | plan? |
| Dec 17, 2018 AForm 4 → | Dec 19, 3:58 pm EST | Ralph AlvarezDirector | 101 | $108.36 | $10,944 | 43,278 | — | plan? |
| Dec 17, 2018 AForm 4 → | Dec 19, 3:53 pm EST | J Erik FyrwaldDirector | 50 | $108.36 | $5,418 | 61,694 | — | plan? |
| Dec 17, 2018 AForm 4 → | Dec 19, 3:51 pm EST | Juan R LucianoDirector | 89 | $108.36 | $9,644 | 8,114 | — | plan? |
| Dec 10, 2018 SForm 4 → | Dec 12, 3:15 pm EST | Myles O'NeillSVP & Pres., Mfg. Operations | 25,000 | $112.92 | $2,822,959 | 50,954 | −32.9% | plan? amended |
| Dec 4, 2018 SForm 4 → | Dec 6, 3:43 pm EST | LILLY ENDOWMENT INC10% Owner | 15,500 | $119.00 | $1,844,536 | 118,015,304 | −0.01% | plan? |
| Dec 2, 2018 FMForm 4 → | Dec 4, 3:14 pm EST | Anne E. WhiteSVP & Pres-Lilly Oncology | 10,806 | $118.64 | $392,224 | 13,797 | — | plan? |
| Nov 29, 2018 SForm 4 → | Nov 30, 11:52 am EST | LILLY ENDOWMENT INC10% Owner | 185,000 | $117.42 | $21,722,429 | 118,030,804 | −0.16% | plan? |
| Nov 28, 2018 SForm 4 → | Nov 29, 10:55 am EST | LILLY ENDOWMENT INC10% Owner | 190,000 | $115.57 | $21,957,939 | 118,215,804 | −0.16% | plan? |
| Nov 19, 2018 AForm 4 → | Nov 20, 6:19 pm EST | Jamere JacksonDirector | 1,511 | $115.81 | $174,989 | 4,016 | — | plan? |
| Nov 19, 2018 AForm 4 → | Nov 20, 6:15 pm EST | Katherine BaickerDirector | 1,511 | $115.81 | $174,989 | 16,797 | — | plan? |
| Nov 19, 2018 AForm 4 → | Nov 20, 5:53 pm EST | Jackson P TaiDirector | 1,511 | $115.81 | $174,989 | 54,786 | — | plan? |
| Nov 19, 2018 AForm 4 → | Nov 20, 5:51 pm EST | Kathi P SeifertDirector | 1,511 | $115.81 | $174,989 | 71,370 | — | plan? |
| Nov 19, 2018 AForm 4 → | Nov 20, 5:47 pm EST | Marschall S RungeDirector | 1,511 | $115.81 | $174,989 | 11,014 | — | plan? |
| Nov 19, 2018 AForm 4 → | Nov 20, 5:44 pm EST | Ellen R MarramDirector | 1,511 | $115.81 | $174,989 | 55,908 | — | plan? |
| Nov 19, 2018 AForm 4 → | Nov 20, 5:41 pm EST | Juan R LucianoDirector | 1,594 | $115.81 | $184,601 | 8,102 | — | plan? |
| Nov 19, 2018 AForm 4 → | Nov 20, 5:37 pm EST | William G Kaelin Jr.Director | 1,511 | $115.81 | $174,989 | 15,282 | — | plan? |
| Nov 19, 2018 AForm 4 → | Nov 20, 5:32 pm EST | J Erik FyrwaldDirector | 1,558 | $115.81 | $180,432 | 61,441 | — | plan? |
| Nov 19, 2018 AForm 4 → | Nov 20, 5:27 pm EST | Michael L EskewDirector | 1,511 | $115.81 | $174,989 | 39,235 | — | plan? |
| Nov 19, 2018 AForm 4 → | Nov 20, 5:19 pm EST | Carolyn R BertozziDirector | 1,511 | $115.81 | $174,989 | 3,307 | — | plan? |
| Nov 19, 2018 AForm 4 → | Nov 20, 5:16 pm EST | Ralph AlvarezDirector | 1,605 | $115.81 | $185,875 | 43,096 | — | plan? |
| Nov 19, 2018 SForm 4 → | Nov 20, 2:40 pm EST | LILLY ENDOWMENT INC10% Owner | 195,000 | $115.31 | $22,485,572 | 118,405,804 | −0.16% | plan? |
| Nov 16, 2018 SForm 4 → | Nov 19, 1:53 pm EST | LILLY ENDOWMENT INC10% Owner | 200,000 | $113.74 | $22,747,000 | 118,600,804 | −0.17% | plan? |
| Nov 13, 2018 SForm 4 → | Nov 14, 10:44 am EST | LILLY ENDOWMENT INC10% Owner | 2,460 | $113.41 | $278,979 | 118,800,804 | −0.00% | plan? |
| Nov 12, 2018 SForm 4 → | Nov 13, 10:51 am EST | LILLY ENDOWMENT INC10% Owner | 202,540 | $113.48 | $22,984,877 | 118,803,264 | −0.17% | plan? |
| Nov 9, 2018 GForm 5 → | Feb 1, 2019, 2:04 pm EST | Donald A ZakrowskiChief Accounting Officer | 180 | — | — | 3,350 | — | plan? |
| Nov 9, 2018 GForm 5 → | Feb 1, 2019, 2:00 pm EST | Aarti S. ShahSVP & CIO | 1,424 | — | — | 14,285 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2026 MForm 4 → | Aug 3, 4:42 pm EDT | Melissa SeymourEVP, Global Quality | 981 | — | — | 952 | — | |
| Feb 16, 2019 MForm 4 → | Feb 20, 3:52 pm EST | Johna NortonSenior VP, Global Quality | 48 | — | — | 97 | — | |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:58 pm EST | Alfonso G ZuluetaSVP & President, Lilly Int'l | 16,317 | — | — | 16,317 | — | |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:29 pm EST | David A RicksPresident & CEO, Director | 69,350 | — | — | 69,350 | — | |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:16 pm EST | Michael J HarringtonSenior VP and General Counsel | 18,765 | — | — | 18,765 | — | amended |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:10 pm EST | Stephen F FrySVP, HR & Diversity | 13,055 | — | — | 13,055 | — | amended |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:02 pm EST | Enrique A ConternoSVP&Pres, LillyDiab & LillyUSA | 20,397 | — | — | 20,397 | — | amended |
| Feb 4, 2019 AForm 4 → | Feb 6, 7:00 pm EST | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 4,896 | — | — | 4,896 | — | |
| Feb 1, 2019 MForm 4 → | Feb 6, 8:10 pm EST | Myles O'NeillSVP & Pres., Mfg. Operations | 3,221 | — | — | 0 | — | late amended |
| Feb 1, 2019 MForm 4 → | Feb 5, 7:09 pm EST | Alfonso G ZuluetaSVP & President, Lilly Int'l | 9,722 | — | — | 0 | — | |
| Feb 1, 2019 MForm 4 → | Feb 5, 7:04 pm EST | David A RicksPresident & CEO, Director | 12,222 | — | — | 0 | — | |
| Feb 1, 2019 MForm 4 → | Feb 5, 6:59 pm EST | Michael J HarringtonSenior VP and General Counsel | 12,778 | — | — | 0 | — | |
| Feb 1, 2019 MForm 4 → | Feb 5, 6:55 pm EST | Stephen F FrySVP, HR & Diversity | 8,889 | — | — | 0 | — | |
| Feb 1, 2019 MForm 4 → | Feb 5, 6:49 pm EST | Enrique A ConternoSVP&Pres, LillyDiab & LillyUSA | 12,222 | — | — | 0 | — | |
| Feb 1, 2019 MForm 4 → | Feb 5, 6:43 pm EST | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 3,333 | — | — | 0 | — | |
| Dec 2, 2018 MForm 4 → | Dec 4, 3:14 pm EST | Anne E. WhiteSVP & Pres-Lilly Oncology | 7,500 | — | — | 0 | — | |
| Nov 3, 2018 MForm 4 → | Nov 6, 1:25 pm EST | Johna NortonSenior VP, Global Quality | 3,133 | — | — | 0 | — | |
| Jul 5, 2018 MForm 4 → | Jul 9, 11:58 am EDT | Leigh Ann PuseySVP, Corp. Affairs & Comm. | 2,394 | — | — | 4,862 | — | |
| May 1, 2018 MForm 4 → | May 3, 4:34 pm EDT | Jeffrey N SimmonsSVP&Pres. Elanco Animal Health | 20,000 | — | — | 0 | — | |
| May 1, 2018 MForm 4 → | May 3, 4:29 pm EDT | Christi ShawSVP and Pres., Lilly Bio-Meds | 13,750 | — | — | 13,750 | — | |
| May 1, 2018 MForm 4 → | May 3, 4:26 pm EDT | Enrique A ConternoSVP&Pres, LillyDiab & LillyUSA | 20,000 | — | — | 0 | — | |
| Feb 16, 2018 MForm 4 → | Feb 21, 10:28 am EST | Johna NortonSenior VP, Global Quality | 48 | — | — | 145 | — | |
| Feb 9, 2018 AForm 4 → | Feb 13, 10:47 am EST | Jan M LundbergEVP,Science&Tech and Pres. LRL | 7,871 | — | — | 7,871 | — | |
| Feb 1, 2018 MForm 4 → | Sep 24, 4:45 pm EDT | Myles O'NeillSVP & Pres., Mfg. Operations | 9,596 | — | — | 0 | — | late |
| Feb 1, 2018 MForm 4 → | Feb 5, 6:37 pm EST | Jeffrey N SimmonsSVP&Pres. Elanco Animal Health | 21,326 | — | — | 0 | — | |
| Feb 1, 2018 MForm 4 → | Feb 5, 6:33 pm EST | Alfonso G ZuluetaSVP & President, Lilly Int'l | 15,993 | — | — | 0 | — | |
| Feb 1, 2018 MForm 4 → | Feb 5, 6:31 pm EST | David A RicksPresident & CEO, Director | 21,326 | — | — | 0 | — | |
| Feb 1, 2018 MForm 4 → | Feb 5, 6:24 pm EST | Susan MahonySVP & Pres., Lilly Oncology | 21,326 | — | — | 0 | — | |
| Feb 1, 2018 MForm 4 → | Feb 5, 6:21 pm EST | Jan M LundbergEVP,Science&Tech and Pres. LRL | 36,252 | — | — | 0 | — | |
| Feb 1, 2018 MForm 4 → | Feb 5, 6:19 pm EST | Michael J HarringtonSenior VP and General Counsel | 24,524 | — | — | 0 | — | |
| Feb 1, 2018 MForm 4 → | Feb 5, 6:15 pm EST | Stephen F FrySVP, HR & Diversity | 17,060 | — | — | 0 | — | |
| Feb 1, 2018 MForm 4 → | Feb 5, 6:12 pm EST | Enrique A ConternoSVP&Pres, LillyDiab & LillyUSA | 21,326 | — | — | 0 | — | |
| Feb 1, 2018 MForm 4 → | Feb 5, 6:09 pm EST | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 6,398 | — | — | 0 | — | |
| Jan 29, 2018 AForm 4 → | Jan 31, 6:15 pm EST | Alfonso G ZuluetaSVP & President, Lilly Int'l | 9,722 | — | — | 9,722 | — | |
| Jan 29, 2018 AForm 4 → | Jan 31, 6:13 pm EST | Michael J HarringtonSenior VP and General Counsel | 12,778 | — | — | 12,778 | — | |
| Jan 29, 2018 AForm 4 → | Jan 31, 6:07 pm EST | Jeffrey N SimmonsSVP&Pres. Elanco Animal Health | 11,111 | — | — | 11,111 | — | |
| Jan 29, 2018 AForm 4 → | Jan 31, 6:06 pm EST | Susan MahonySVP & Pres., Lilly Oncology | 11,111 | — | — | 11,111 | — | amended |
| Jan 29, 2018 AForm 4 → | Jan 31, 6:00 pm EST | David A RicksPresident & CEO, Director | 12,222 | — | — | 12,222 | — | |
| Jan 29, 2018 AForm 4 → | Jan 31, 6:00 pm EST | Stephen F FrySVP, HR & Diversity | 8,889 | — | — | 8,889 | — | |
| Jan 29, 2018 AForm 4 → | Jan 31, 5:57 pm EST | Enrique A ConternoSVP&Pres, LillyDiab & LillyUSA | 12,222 | — | — | 12,222 | — | |
| Jan 29, 2018 AForm 4 → | Jan 31, 5:57 pm EST | Jan M LundbergEVP,Science&Tech and Pres. LRL | 20,000 | — | — | 20,000 | — | |
| Jan 29, 2018 AForm 4 → | Jan 31, 5:55 pm EST | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 3,333 | — | — | 3,333 | — | |
| Dec 11, 2017 AForm 4 → | Dec 13, 3:05 pm EST | Enrique A ConternoSVP&Pres, LillyDiab & LillyUSA | 34,615 | — | — | 34,615 | — | |
| Dec 3, 2017 MForm 4 → | Dec 5, 5:48 pm EST | Donald A ZakrowskiChief Accounting Officer | 3,281 | — | — | 0 | — | |
| Dec 3, 2017 MForm 4 → | Dec 5, 5:46 pm EST | Stephen F FrySVP, HR & Diversity | 7,557 | — | — | 0 | — | |
| Dec 3, 2017 MForm 4 → | Dec 5, 5:43 pm EST | David A RicksPresident & CEO, Director | 5,496 | — | — | 0 | — | |
| Jul 5, 2017 AForm 4 → | Jul 7, 9:58 am EDT | Leigh Ann PuseySVP, Corp. Affairs & Comm. | 7,256 | — | — | 7,256 | — | |
| May 1, 2017 AForm 4 → | May 8, 3:53 pm EDT | Christi ShawSVP and Pres., Lilly Bio-Meds | 27,500 | — | — | 27,500 | — | late |
| Feb 1, 2017 MForm 4 → | Feb 3, 5:20 pm EST | Derica W RiceEVP-Global Services and CFO | 19,463 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 3:24 pm EST | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 3,073 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 3:20 pm EST | Alfonso G ZuluetaSVP& Pres., Emerging Markets | 6,659 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 3:18 pm EST | Fionnuala M WalshSVP, Global Quality | 4,610 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 3:16 pm EST | Jeffrey N SimmonsSVP&Pres. Elanco Animal Health | 10,244 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 3:13 pm EST | David A RicksPresident & CEO, Director | 10,244 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 3:11 pm EST | Barton R PetersonSr. VP, Corp. Affairs & Comm. | 5,634 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 3:08 pm EST | Susan MahonySVP & Pres., Lilly Oncology | 9,732 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 3:04 pm EST | Jan M LundbergEVP,Science&Tech and Pres. LRL | 15,366 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 3:01 pm EST | John C LechleiterDirector | 46,097 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 2:58 pm EST | Michael J HarringtonSenior VP and General Counsel | 9,732 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 2:53 pm EST | Stephen F FrySVP, HR & Diversity | 7,683 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 2:41 pm EST | Maria A CrowePresident, Mfg. Operations | 8,195 | — | — | 0 | — | |
| Feb 1, 2017 MForm 4 → | Feb 3, 2:35 pm EST | Enrique A ConternoSr. VP & Pres., Lilly Diabetes | 10,244 | — | — | 0 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 6:34 pm EST | Alfonso G ZuluetaSVP& Pres., Emerging Markets | 15,993 | — | — | 15,993 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 6:29 pm EST | Fionnuala M WalshSVP, Global Quality | 9,596 | — | — | 9,596 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 6:27 pm EST | Jeffrey N SimmonsSVP&Pres. Elanco Animal Health | 21,326 | — | — | 21,326 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 6:21 pm EST | David A RicksPresident & CEO, Director | 21,326 | — | — | 21,326 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 6:18 pm EST | Derica W RiceEVP-Global Services and CFO | 40,518 | — | — | 40,518 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 6:16 pm EST | Barton R PetersonSr. VP, Corp. Affairs & Comm. | 11,729 | — | — | 11,729 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 6:13 pm EST | Susan MahonySVP & Pres., Lilly Oncology | 21,326 | — | — | 21,326 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 6:09 pm EST | Jan M LundbergEVP,Science&Tech and Pres. LRL | 36,252 | — | — | 36,252 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 6:06 pm EST | John C LechleiterDirector | 106,625 | — | — | 106,625 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 6:03 pm EST | Michael J HarringtonSenior VP and General Counsel | 24,524 | — | — | 24,524 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 5:57 pm EST | Stephen F FrySVP, HR & Diversity | 17,060 | — | — | 17,060 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 5:53 pm EST | Maria A CrowePresident, Mfg. Operations | 17,060 | — | — | 17,060 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 5:51 pm EST | Enrique A ConternoSr. VP & Pres., Lilly Diabetes | 21,326 | — | — | 21,326 | — | |
| Jan 27, 2017 AForm 4 → | Jan 31, 5:47 pm EST | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 6,398 | — | — | 6,398 | — | |
| Dec 1, 2016 MForm 4 → | Dec 5, 2:29 pm EST | Susan MahonySVP & Pres., Lilly Oncology | 4,584 | — | — | 0 | — | |
| Oct 2, 2016 MForm 4 → | Oct 4, 2:32 pm EDT | Maria A CrowePresident, Mfg. Operations | 22,480 | — | — | 0 | — | |
| Oct 2, 2016 MForm 4 → | Oct 4, 2:27 pm EDT | Fionnuala M WalshSVP, Global Quality | 3,760 | — | — | 0 | — | |
| Oct 2, 2016 MForm 4 → | Oct 4, 2:08 pm EDT | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 3,894 | — | — | 0 | — | |
| Aug 31, 2016 MForm 4 → | Sep 1, 3:58 pm EDT | Jeffrey N SimmonsSVP&Pres. Elanco Animal Health | 6,556 | — | — | 0 | — | |
| Aug 3, 2016 MForm 4 → | Aug 5, 11:08 am EDT | Fionnuala M WalshSVP, Global Quality | 7,500 | — | — | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 2:09 pm EST | Fionnuala M WalshSVP, Global Quality | 4,144 | — | — | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 2:06 pm EST | Jeffrey N SimmonsSVP&Pres. Elanco Animal Health | 9,843 | $79.10 | $778,581 | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 2:04 pm EST | David A RicksSVP and Pres, Lilly Bio-Meds | 9,843 | — | — | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 2:02 pm EST | Derica W RiceEVP-Global Services and CFO | 19,685 | — | — | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 2:00 pm EST | Barton R PetersonSr. VP, Corp. Affairs & Comm. | 5,698 | — | — | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 1:58 pm EST | Susan MahonySVP & Pres., Lilly Oncology | 9,843 | — | — | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 1:55 pm EST | Jan M LundbergEVP,Science&Tech and Pres. LRL | 15,541 | — | — | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 1:54 pm EST | John C LechleiterChairman, President and CEO, Director | 46,623 | — | — | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 1:52 pm EST | Michael J HarringtonSenior VP and General Counsel | 9,066 | — | — | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 1:50 pm EST | Stephen F FrySVP, HR & Diversity | 7,252 | — | — | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 1:48 pm EST | Maria A CrowePresident, Mfg. Operations | 7,252 | — | — | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 1:46 pm EST | Enrique A ConternoSr. VP & Pres., Lilly Diabetes | 10,360 | — | — | 0 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 1:43 pm EST | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 2,072 | — | — | 0 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:57 pm EST | Alfonso G ZuluetaSVP& Pres., Emerging Markets | 6,659 | — | — | 6,659 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:56 pm EST | Michael J HarringtonSenior VP and General Counsel | 9,732 | — | — | 9,732 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:55 pm EST | Melissa S BarnesChief Eth/Cmpl Ofcr & SVP, ERM | 3,073 | — | — | 3,073 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:53 pm EST | Maria A CrowePresident, Mfg. Operations | 8,195 | — | — | 8,195 | — | |
| Jan 26, 2016 AForm 4 → | Jan 28, 6:52 pm EST | David A RicksSVP and Pres, Lilly Bio-Meds | 10,244 | — | — | 10,244 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2019 DForm 4 → | Mar 11, 8:03 am EDT | Elanco Animal Health IncELAN | 293,290,000 | — | — | 0 | — | plan? |
| Jan 31, 2019 SForm 4 → | Feb 4, 4:36 pm EST | Zymeworks Inc.ZYME | 250,000 | $16.00 | $4,000,000 | 2,898,647 | −7.94% | plan? amended |
| Nov 6, 2018 SForm 4 → | Nov 8, 11:34 am EST | Zymeworks Inc.ZYME | 700,000 | $14.00 | $9,800,000 | 3,148,647 | −18.2% | plan? |
| Sep 24, 2018 SForm 4 → | Sep 26, 2:50 pm EDT | Zymeworks Inc.ZYME | 2,027 | $16.36 | $33,162 | 3,848,647 | −0.05% | plan? |
| Sep 18, 2018 SForm 4 → | Sep 20, 4:50 pm EDT | Zymeworks Inc.ZYME | 6,870 | $14.56 | $100,027 | 3,850,674 | −0.18% | plan? |
| Sep 14, 2018 SForm 4 → | Sep 18, 7:30 pm EDT | Zymeworks Inc.ZYME | 15,874 | $14.58 | $231,443 | 3,857,544 | −0.41% | plan? |
| Sep 12, 2018 SForm 4 → | Sep 14, 3:34 pm EDT | Zymeworks Inc.ZYME | 30,959 | $14.49 | $448,463 | 3,873,418 | −0.79% | plan? |
| Sep 10, 2018 SForm 4 → | Sep 12, 4:39 pm EDT | Zymeworks Inc.ZYME | 15,777 | $14.75 | $232,669 | 3,904,377 | −0.40% | plan? |
| Aug 31, 2018 SForm 4 → | Sep 4, 3:38 pm EDT | Zymeworks Inc.ZYME | 700 | $14.26 | $9,982 | 3,920,154 | −0.02% | plan? |
| Aug 29, 2018 SForm 4 → | Aug 31, 12:40 pm EDT | Zymeworks Inc.ZYME | 5,752 | $14.31 | $82,333 | 3,920,854 | −0.15% | plan? |
| Aug 14, 2018 SForm 4 → | Aug 16, 3:34 pm EDT | Zymeworks Inc.ZYME | 3,000 | $14.28 | $42,840 | 3,926,606 | −0.08% | plan? |
| Aug 10, 2018 SForm 4 → | Aug 14, 5:04 pm EDT | Zymeworks Inc.ZYME | 6,429 | $14.32 | $92,033 | 3,929,606 | −0.16% | plan? |
| Aug 3, 2018 SForm 4 → | Aug 7, 3:16 pm EDT | Zymeworks Inc.ZYME | 1,650 | $13.55 | $22,358 | 3,936,035 | −0.04% | plan? |
| Aug 2, 2018 SForm 4 → | Aug 3, 3:53 pm EDT | Zymeworks Inc.ZYME | 19,400 | $13.31 | $258,214 | 3,937,685 | −0.49% | plan? |
| Mar 1, 2017 JForm 4 → | Mar 1, 5:02 pm EST | CoLucid Pharmaceuticals, Inc.CLCD | 19,285,108 | $46.50 | $896,757,522 | 100 | — | plan? |
| Apr 12, 2016 CForm 4/A → | Apr 14, 7:35 pm EDT | Aeglea BioTherapeutics, Inc.AGLE | 2,010,924 | — | — | 2,068,543 | — | plan? |
| Apr 12, 2016 PForm 4 → | Apr 14, 6:41 pm EDT | Aeglea BioTherapeutics, Inc.AGLE | 500,000 | $10.00 | $5,000,000 | 2,568,543 | +24.2% | plan? |
| Apr 12, 2016 CForm 4 → | Apr 14, 6:41 pm EDT | Aeglea BioTherapeutics, Inc.AGLE | 2,010,924 | — | — | 2,068,543 | — | plan? |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2018 AForm 4 → | Aug 13, 5:30 pm EDT | LEAP THERAPEUTICS, INC.LPTX | 331,221 | — | — | 331,221 | — | late |
| Apr 12, 2016 CForm 4 → | Apr 14, 6:41 pm EDT | Aeglea BioTherapeutics, Inc.AGLE | 2,010,924 | — | — | 0 | — |